Results 61 to 70 of about 12,552 (166)

Endobronchial Lesion in Eosinophilic Granulomatosis with Polyangiitis

Iranian Journal of Allergy, Asthma and Immunology, 2017
Eosinophilic granulomatosis with polyangiitis is a systemic vasculitis. It could affect respiratory system, kidney, and central nervous system frequently; however, all body organs could be involved.
Guan-Liang Chen, Chun-Han Wu, Wann-Cherng Perng   +2 more
doaj  

Remission in Global Airway Diseases: EUFOREA Consensus Paper

Allergy, EarlyView.
ABSTRACT The therapeutic goal in chronic airway diseases is shifting from symptom control to disease remission. Disease‐modifying therapies, including biologics and allergen immunotherapy, have made remission achievable in patients with severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), or allergic rhinitis (AR).
J. Christian Virchow, Xander Bertels, Vibeke Backer, Benjamin S. Bleier, Marco Caminati, Diego M. Conti, Eugenio De Corso, Mina Gaga, Valerie J. Lund, Corrado Pelaia, Anju T. Peters, Glenis K. Scadding, Martin Wagenmann, Riyad O. Al‐Lehebi, Guy G. Brusselle, Philippe Gevaert, Liam G. Heaney, Stella E. Lee, Florence Schleich, Frederik Trinkmann, Peter W. Hellings, Wytske J. Fokkens, Paola Rogliani   +22 more
wiley   +1 more source

Cytomegalovirus Disease in a Patient With Granulomatosis With Polyangiitis Who Also Has Splenic Necrosis

The Turkish Journal of Gastroenterology, 2019
Cytomegalovirus infection, which can occur as a result of reactivation due to immunosuppressive treatment in patients with granulomatosis with polyangiitis, is a serious condition that should be kept in mind because of its fatal course. In this article,
Önay GERÇİK, Dilek SOLMAZ, Şebnem KARASU, Neşe EKİNCİ, Servet AKAR   +4 more
doaj  

Differential diagnosis of granulomatous lung disease: clues and pitfalls

European Respiratory Review, 2017
Granulomatous lung diseases are a heterogeneous group of disorders that have a wide spectrum of pathologies with variable clinical manifestations and outcomes.
Shinichiro Ohshimo, Josune Guzman, Ulrich Costabel, Francesco Bonella   +3 more
doaj   +1 more source

Management of Non‐Plaque‐Induced Gingival Conditions: A Systematic Review—Part 2: Inflammatory and Immune Conditions; Neoplasms; and Gingival Pigmentation

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra, Cecile Wasielewski, Bruno Špiljak, Maja Sabalić‐Schoener, Sebastien Jungo, Ivan Alajbeg   +5 more
wiley   +1 more source

A presentation of recurrent cerebral ischemic stroke in eosinophilic granulomatosis with polyangiitis: a case report

Journal of Medical Case Reports
Background Eosinophilic granulomatosis with polyangiitis is characterized as a small vessel vasculitis with the propensity to have a myriad of presentations due to the targeting of several different organ systems. More often than not, it is the pulmonary
Bryan Gregory, Ahmed Dawood Al Mahrizi, Harman Gill, Fatima Mossolem, Song Ang Peng, Randy Rueda, Eunseuk Lee   +6 more
doaj   +1 more source

Granulomatosis With Polyangiitis (Wegener Granulomatosis): Then and Now

Archives of Pathology & Laboratory Medicine
Context.— In 1954 Godman and Churg published an article in the Archives of Pathology & Laboratory Medicine entitled “Wegener’s Granulomatosis” (now replaced by “granulomatosis with polyangiitis” [GPA]) and linked various forms of what is ...
Andrew, Churg, Nestor L, Muller
openaire   +2 more sources

A case of hereditary alpha tryptasemia and presumptive eosinophilic granulomatosis with polyangiitis

Journal of Allergy and Clinical Immunology: Global
This case is notable for the potential overlap of hereditary alpha tryptasemia and eosinophilic granulomatosis with polyangiitis. The successful use of mepolizumab, initially for eosinophilic granulomatosis with polyangiitis but potentially benefiting ...
Sonia Iqbal, DO, Joseph A. Baxter, DO, Karla E. Adams, MD   +2 more
doaj   +1 more source

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective To evaluate the six‐month effectiveness and safety of rituximab biosimilars compared to the originator in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), and outcomes following originator to biosimilar switching. Methods We recruited adults with GPA or MPA treated with the rituximab originator or a biosimilar for ...
Arielle Mendel, Lillian Barra, Hassan Behlouli, Sasha Bernatsky, Alison H. Clifford, Jan Willem Cohen Tervaert, Natasha Dehghan, Aurore Fifi‐Mah, Jean‐Paul Makhzoum, Rosalie‐Sélène Meunier, Nataliya Milman, Medha Soowamber, Elaine Yacyshyn, Nader Khalidi, Christian Pagnoux   +14 more
wiley   +1 more source

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT

Сибирский научный медицинский журнал, 2020
The aim of the research is to study nosological structure, features of kidney, lung damage, deaths in patients with ANCA – associated vasculitis underwent medical treatment in a multidisciplinary hospital. Material and methods.
L. M. Kudelya, Ya. L. Manakova, E. S. Khusainova, E. A. Drobyazgin, A. V. Kutepov, A. M. Gorbovskaya, A. V. Korobeynikov, L. A. Bogoderova, I. A. Zubritskaya, V. F. Khusainov, K. I. Shcherbina   +10 more
doaj   +1 more source